Atlas Trials

Managed Access Programs for LNP023, Iptacopan

Clinical trial NCT05222412 · AVAILABLE

Trial details

NCT number
NCT05222412
Sponsor
Novartis Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
C3 Glomerulopathy (C3G)Paroxysmal Nocturnal Hemoglobinuria (PNH)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.